Nicotinamide adenine dinucleotide (NAD+) intravenous (IV) therapy

Nicotinamide adenine dinucleotide (NAD+) intravenous (IV) therapy supplies an individual with a coenzyme that plays a crucial role in various cellular processes, including energy metabolism and DNA repair. NAD+ IV therapy has gained attention for its potential benefits. The scientific evidence is still limited. Research is ongoing.

Key points: